LAMICTAL
Active substance: lamotrigine
TABLET, FOR SUSPENSION · LAMOTRIGINE 2 mg/1
United StatesActive
Marketing holder: GlaxoSmithKline LLC
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
- LAMOTRIGINE · 2 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 29 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-31ca-7d01-be4c-60a69c350382,01a120c3-356a-7f58-8be3-9ad33520133a,01a120c3-371e-790d-b2a7-6c164b633544,01a120c3-38e4-700d-84c7-f2d859c0fd0e,01a120c3-3965-7e74-8be2-c87f4b09edad;count=23 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2d6a-7c76-b7f0-b9a246b9a15c,01a1208c-34a3-7e50-b0a0-c902b25fdebc,01a1208c-3888-7b9c-8cf9-e6245db8c703,01a1208c-3dfb-7b26-85c2-29feafecd627,01a1208c-48b9-7c6d-a1bd-59067498cd24;count=303 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 0173-0699
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 0173-0699 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0173-0699 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0173-0699 · Verified 2026-10-09 · open in source